CT-18 (OXYPIK)

Cardiac, nervous, or bronchial asthma, spasmodic cough etc.

Composition:

Each tablet contains:                                                                                                                         

• Kali phos 6x 24.2% w/w
• Mag phos 6x 24.2% w/w
• Nat mur 6x 24.2% w/w
• Nat sulph 6x 24.2% w/w

With excipients q.s. to tablet weight.

Drug Facts:

Kali phos: Asthma; least food aggravates. Short breath on going upstairs. Cough; yellow expectoration.

Mag phos: Asthmatic oppression of chest. Dry, tickling cough. Spasmodic cough, with difficulty in lying down. Whooping cough.

Nat mur: Cough from a tickling in the pit of stomach. Stitches all over chest. Cough, with bursting pain in head. Whooping cough with flow of tears with cough.

Nat sulph: Every fresh cold brings on attack of asthma. Cough, with thick ropy, greenish expectoration; chest feel all gone. Must hold chest when coughing. Humid asthma; rattling in chest.

Side effects:

No side effects of OXYPIK are known.

Contraindications:

No contraindication for the use of OXYPIK are known till date.

Interactions:

No interactions between OXYPIK and other products are known.

Note: Use within 5 years of manufacturing.